Signe W Worm

Summary

Affiliation: Hvidovre University Hospital
Country: Denmark

Publications

  1. ncbi Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke
    S W Worm
    Copenhagen HIV Programme, University of Copenhagen, Denmark
    J Infect Dis 205:535-9. 2012
  2. ncbi Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study
    Signe W Worm
    Copenhagen HIV Programme, University of Copenhagen, Copenhagen, Denmark
    Diabetes Care 32:474-80. 2009
  3. ncbi Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study)
    Signe W Worm
    Copenhagen HIV Programme, University of Copenhagen Faculty of Health Science, Bldg 21 1 Blegdamsvej 3B, DK 2200 Copenhagen, Denmark
    Circulation 119:805-11. 2009
  4. ncbi High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome
    Signe W Worm
    Copenhagen HIV Programme, University of Copenhagen, Copenhagen, Denmark
    AIDS 24:427-35. 2010
  5. ncbi Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study
    Signe Westring Worm
    Copenhagen HIV Programme, University of Copenhagen, Copenhagen, Denmark
    J Infect Dis 201:318-30. 2010
  6. ncbi Role of biomarkers in predicting CVD risk in the setting of HIV infection?
    Signe W Worm
    Copenhagen HIV Programme, University of Copenhagen, Copenhagen, Denmark
    Curr Opin HIV AIDS 5:467-72. 2010
  7. ncbi Elevated triglycerides and risk of myocardial infarction in HIV-positive persons
    Signe W Worm
    Copenhagen HIV Programme, University of Copenhagen, Denmark
    AIDS 25:1497-504. 2011
  8. ncbi The metabolic syndrome in HIV
    Signe W Worm
    Copenhagen HIV Programme, University of Copenhagen, Faculty of Health Science, Blegdamsvej, Copenhagen N, Denmark
    Best Pract Res Clin Endocrinol Metab 25:479-86. 2011

Detail Information

Publications8

  1. ncbi Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke
    S W Worm
    Copenhagen HIV Programme, University of Copenhagen, Denmark
    J Infect Dis 205:535-9. 2012
    ..22; 95% confidence interval, .95-1.57), whereas cumulative exposure to PIs was associated with an increased risk (adjusted rate ratio, 1.06 per year of exposure; 95% confidence interval, 1.01-1.11)...
  2. ncbi Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study
    Signe W Worm
    Copenhagen HIV Programme, University of Copenhagen, Copenhagen, Denmark
    Diabetes Care 32:474-80. 2009
    ..Among HIV-infected individuals, we investigated whether any particular combinations of the components included in the definition of the metabolic syndrome are associated with a higher risk of cardiovascular disease (CVD)...
  3. ncbi Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study)
    Signe W Worm
    Copenhagen HIV Programme, University of Copenhagen Faculty of Health Science, Bldg 21 1 Blegdamsvej 3B, DK 2200 Copenhagen, Denmark
    Circulation 119:805-11. 2009
    ..We investigated the impact of DM and preexisting CHD on the development of a new CHD episode among 33,347 HIV-infected individuals in the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study)...
  4. ncbi High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome
    Signe W Worm
    Copenhagen HIV Programme, University of Copenhagen, Copenhagen, Denmark
    AIDS 24:427-35. 2010
    ....
  5. ncbi Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study
    Signe Westring Worm
    Copenhagen HIV Programme, University of Copenhagen, Copenhagen, Denmark
    J Infect Dis 201:318-30. 2010
    ..As with any observational study, our findings must be interpreted with caution (given the potential for confounding) and in the context of the benefits that these drugs provide...
  6. ncbi Role of biomarkers in predicting CVD risk in the setting of HIV infection?
    Signe W Worm
    Copenhagen HIV Programme, University of Copenhagen, Copenhagen, Denmark
    Curr Opin HIV AIDS 5:467-72. 2010
    ..The purpose of this review is to present recent results on biomarkers and risk of cardiovascular disease (CVD) in the general population and to review studies of biomarkers among individuals with HIV infection...
  7. ncbi Elevated triglycerides and risk of myocardial infarction in HIV-positive persons
    Signe W Worm
    Copenhagen HIV Programme, University of Copenhagen, Denmark
    AIDS 25:1497-504. 2011
    ....
  8. ncbi The metabolic syndrome in HIV
    Signe W Worm
    Copenhagen HIV Programme, University of Copenhagen, Faculty of Health Science, Blegdamsvej, Copenhagen N, Denmark
    Best Pract Res Clin Endocrinol Metab 25:479-86. 2011
    ..Based on a limited number of studies on MS in HIV with clinical end-points, there is no data to support that the MS is independently associated with an increased risk of CVD...